Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02100566 · ClinicalTrials.gov registry record · NA
Behavioral Economics for Advance Care Options
A NA study, sponsored by Ascension Health.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02100566 is a NA study that has completed, run by Ascension Health. The registered enrollment target is 80 participants.
The verdict
NCT02100566, a NA study, has completed, sponsored by Ascension Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
People with life-limiting illness often receive more aggressive healthcare than desired including costly procedures that provide little medical benefit. Advance Directives (AD) can reduce this effect but various factors limit their adoption. A randomized trial will target hospitalized patients with a serious, life limiting illness to test if the behavioral economics principles of endowment (possessing something) and focusing (featuring something important to patients) can motivate AD completion. Investigators will examine if offering patients an AD by default, in combination with framing the rationale for AD completion (emphasizing patient control or caregiver burden) improves AD completion and family conversation compared to a no-intervention group. The study hypothesis is to determine if rates of AD completion and family conversations will be highest among patients receiving the intervention focused on reduced caregiver burden; and if the two intervention groups will have higher rates of both than the control group. The investigators suspect that a small change in how patient information is framed (endowment and focusing used in tandem) will potentially leverage large increases in AD completion and that targeting HHC patients allows AD discussions early in the disease trajectory when they can participate in care decisions.
Interventions
- BEHAVIORAL Counseling (Care giver burden focus)
- BEHAVIORAL Counseling (patient autonomy focus)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02100566
The ClinicalTrials.gov registry entry for NCT02100566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascension Health, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Counseling (Care giver burden focus) is the first listed.
NCT02100566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02100566 about?
NCT02100566 is a clinical study titled "Behavioral Economics for Advance Care Options". People with life-limiting illness often receive more aggressive healthcare than desired including costly procedures that provide little medical benefit. Advance Directives (AD) can reduce this effect but various factors limit their adoption. A randomized trial will target hospitalized patients with...
What is the current status of trial NCT02100566?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2014-04. Estimated completion is 2019-10.
What interventions are being tested in trial NCT02100566?
The interventions under investigation include: Counseling (Care giver burden focus) (BEHAVIORAL), Counseling (patient autonomy focus) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02100566?
This trial is sponsored by Ascension Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.